AL-S Pharma release new data from AP-101 phase 2 trial for ALS
ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
AL-S Pharma release new data from AP-101 phase 2 trial for ALS
ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord
Lilly to acquire Centessa in deal worth up to $7.8bn
The companies aim to advance treatments for narcolepsy and other sleep-wake disorders
Astellas’ application to EMA validated for treatment of muscle-invasive bladder cancer
Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer
Potential US-Iran peace deal to redraw market winners and losers
With a 10-day ceasefire between Israel and Lebanon in effect, oil prices are retreating from recent highs
Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026
The conference will take place from 6 to 7 October 2026 in Copenhagen, Denmark
Latest content
Envision appoints Jay Ferro as President, Technology and Chief Product Officer
Ferro was previously EVP, Chief Information, Technology & Product Officer at Clario
Read More
Richmond Pharmacology appoints John Hotti as Chief Technology Officer
Hotti was previously Head of AI and CIO at Telrock Systems
Read More
Clasado appoints Sebastian Nummelin as new APAC Regional Director
Most recently Nummelin served as Director of APAC at TINE
Read More
CNX Therapeutics appoints David Flint as Chief Corporate Development Officer
Flint most recently held roles at UCB and Solvay
Read More
Intelligence
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
GenAI: embracing the transformation – with caution
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read More
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Communication breakdown
Why soft skills are more important than ever in life sciences
Read More
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Blogs
Latest
Beyond the Linear Path: Leading with Your Full Self
April 21, 2026 | Medscape Education|#HearfromHer #Leadership
Listen to the full episode here. In the latest episode of the Hear From Her podcast, Giulia Ghibellini (Teva Pharmaceuticals) and Professor Amanda Kirby (Do-IT …
Medscape Earns 2026 ANCC NCPD Premier Award for the Second Time, Reaffirming Leadership in Healthcare Education
April 16, 2026 | Medscape Education|
Medscape, the leading digital platform for clinicians around the globe, has earned the 2026 American Nurses Credentialing Center (ANCC) NCPD Premier Award. This prestigious designation …
NEW WEBINAR: Maximizing Speed-to-Outcome for Life Science Companies
April 2, 2026 | Impetus Digital|Advisory board, Pharma trends, Virtual Pharma, asset cocreatio, life science outomes, life science webinar, pharma collaboration, pharma webinar, quality improvement plan, real-world evidence, speed to insight, virtual tools, webinar
Stop losing momentum to the “logistics lag.” The most successful life science teams have moved beyond fragmented spreadsheets and isolated meetings into a unified orchestration …
Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert
April 1, 2026 | Nmblr|Patent cliffs; commercialisation strategy; innovation; biosimilars; biopharma;
With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, …
HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category
March 26, 2026 | Healthcare Research Worldwide|AI, Avatars, Innovation, artificial intelligence, market research
Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of …
Why patient-centricity depends on site-centricity in clinical trials
April 21, 2026 | Cuttsy + Cuttsy|Engagement, Site Teams, Site-centric, clinical research, clinical trials, recruitment, retention
Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.
From cloudy to clear: visualising complex data privacy information
April 17, 2026 | Cuttsy + Cuttsy|clinical trials, communication, health literacy
Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data …
Why pharma website projects stall long before compliance becomes the problem
April 16, 2026 | Genetic Digital|ABPI, Digital, Marketing, Website, compliance, governance, pharma website
Pharma teams often blame compliance when digital projects slow down. In reality, the bigger issue is usually weaker ownership, unclear review models and content structures …
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
April 15, 2026 | Inizio|
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. …